These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor. Mais DE; Halushka PV Prog Clin Biol Res; 1989; 301():303-7. PubMed ID: 2529550 [No Abstract] [Full Text] [Related]
26. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets. Mayeux PR; Morton HE; Gillard J; Lord A; Morinelli TA; Boehm A; Mais DE; Halushka PV Biochem Biophys Res Commun; 1988 Dec; 157(2):733-9. PubMed ID: 2974286 [TBL] [Abstract][Full Text] [Related]
27. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism. Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816 [TBL] [Abstract][Full Text] [Related]
28. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Vezza R; Mezzasoma AM; Venditti G; Gresele P Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439 [TBL] [Abstract][Full Text] [Related]
29. Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis. Fitzgerald DJ; Fragetta J; FitzGerald GA J Clin Invest; 1988 Nov; 82(5):1708-13. PubMed ID: 3183064 [TBL] [Abstract][Full Text] [Related]
30. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets. Watts IS; Wharton KA; White BP; Lumley P Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist. Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721 [TBL] [Abstract][Full Text] [Related]
32. Polyvalent TXA2/PGH2 receptor antagonists with very high affinity. Zehender H; Patscheke H Prog Clin Biol Res; 1989; 301():561-5. PubMed ID: 2529555 [No Abstract] [Full Text] [Related]
33. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro. De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278 [TBL] [Abstract][Full Text] [Related]
34. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Theis JG; Dellweg H; Perzborn E; Gross R Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312 [TBL] [Abstract][Full Text] [Related]
35. Photoaffinity labelling of a thromboxane A2/prostaglandin H2 antagonist binding site in human platelets. Mais DE; Burch RM; Oatis JE; Knapp DR; Halushka PV Biochem Biophys Res Commun; 1986 Oct; 140(1):128-33. PubMed ID: 2946292 [TBL] [Abstract][Full Text] [Related]
36. Thromboxane A2/prostaglandin H2 receptor antagonists. A new therapeutic principle. Patscheke H Stroke; 1990 Dec; 21(12 Suppl):IV139-42. PubMed ID: 2148033 [TBL] [Abstract][Full Text] [Related]
37. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries. Bourgain RH; Andries R; Decuyper K; De Clerck F J Lipid Mediat; 1991; 3(1):3-11. PubMed ID: 1837488 [TBL] [Abstract][Full Text] [Related]
38. 9, 11-Azo-12-oxa-15-hydroxyprostanoic acid: a potent thromboxane synthetase inhibitor and a PGH2/TxA2 receptor antagonist. Kam ST; Portoghese PS Prostaglandins Med; 1979 Nov; 3(5):279-90. PubMed ID: 233035 [TBL] [Abstract][Full Text] [Related]
39. [Thromboxane antagonism in thrombocytes--pathophysiology, pharmacology and possible clinical significance]. Schrör K Wien Klin Wochenschr; 1991; 103(18):543-53. PubMed ID: 1836294 [TBL] [Abstract][Full Text] [Related]